Literature DB >> 19671824

Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy.

Arthur N Lau, Jonathan D Adachi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19671824     DOI: 10.3899/jrheum.081176

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  26 in total

Review 1.  Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw.

Authors:  J Narváez; J A Narváez; C Gómez-Vaquero; J M Nolla
Journal:  Osteoporos Int       Date:  2012-03-08       Impact factor: 4.507

Review 2.  Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015.

Authors:  A Khan; A Morrison; A Cheung; W Hashem; J Compston
Journal:  Osteoporos Int       Date:  2015-10-22       Impact factor: 4.507

Review 3.  Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

Authors:  Robert A Adler; Ghada El-Hajj Fuleihan; Douglas C Bauer; Pauline M Camacho; Bart L Clarke; Gregory A Clines; Juliet E Compston; Matthew T Drake; Beatrice J Edwards; Murray J Favus; Susan L Greenspan; Ross McKinney; Robert J Pignolo; Deborah E Sellmeyer
Journal:  J Bone Miner Res       Date:  2016-01       Impact factor: 6.741

4.  A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.

Authors:  Y Ohbayashi; A Iwasaki; F Nakai; T Mashiba; M Miyake
Journal:  Osteoporos Int       Date:  2019-11-25       Impact factor: 4.507

Review 5.  Current Status of Bone-Forming Therapies for the Management of Osteoporosis.

Authors:  Anne Sophie Koldkjær Sølling; Torben Harsløf; Bente Langdahl
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

Review 6.  Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors:  Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal:  Rheumatol Int       Date:  2013-05-08       Impact factor: 2.631

7.  Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly Japanese woman with severe osteoporosis.

Authors:  Jun Iwamoto; Kaori Yago; Yoshihiro Sato; Hideo Matsumoto
Journal:  Clin Drug Investig       Date:  2012-08-01       Impact factor: 2.859

Review 8.  Parathyroid hormone applications in the craniofacial skeleton.

Authors:  H L Chan; L K McCauley
Journal:  J Dent Res       Date:  2012-10-15       Impact factor: 6.116

9.  Role of parathyroid hormone therapy in reversing radiation-induced nonunion and normalization of radiomorphometrics in a murine mandibular model of distraction osteogenesis.

Authors:  K Kelly Gallagher; Sagar Deshpande; Catherine N Tchanque-Fossuo; Alexis Donneys; Deniz Sarhaddi; Noah S Nelson; Douglas B Chepeha; Steven R Buchman
Journal:  Head Neck       Date:  2013-01-17       Impact factor: 3.147

Review 10.  Bisphosphonate Related Osteonecrosis of the Jaw: An Update.

Authors:  Vijay Kumar; Raman Kant Sinha
Journal:  J Maxillofac Oral Surg       Date:  2013-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.